Marketscreener

4 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Health

MarketScreener lists a TWD 240.00 target for Caliway Biopharmaceuticals C stock amid ongoing medical developments.

1 sources 1 articles v 0 3h ago

◼ Archived Business 🔮 fades ✗

Novo Nordisk has halted two clinical trials for Ziltivekimab, an experimental cardiovascular drug designed to reduce inflammation.

1 sources 1 articles v 0 36d ago

◼ Archived Business 🔮 fades ✓

2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

2 sources 2 articles v 1 62d ago

◼ Archived Business 🔮 fades ✓

8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

8 sources 10 articles v 7 61d ago